Abstract
Summary The heat shock protein HSP70 plays antiapoptotic and oncogenic roles, and thus its inhibition has been recognized as a potential avenue for anticancer therapy. Here we describe the small molecule, apoptozole (Az), which inhibits the ATPase activity of HSP70 by binding to its ATPase domain and, as a result, induces an array of apoptotic phenotypes in cancer cells. Affinity chromatography provides evidence that Az binds HSP70 but not other types of heat shock proteins including HSP40, HSP60, and HSP90. We also demonstrate that Az induces cancer cell death via caspase-dependent apoptosis by disrupting the interaction of HSP70 with APAF-1. Animal studies indicate that Az treatment retards tumor growth in a xenograft mouse model without affecting mouse viability. These studies suggest that Az will aid the development of new cancer therapies and serve as a chemical probe to gain a better understanding of the diverse functions of HSP70.
| Original language | English |
|---|---|
| Article number | 3008 |
| Pages (from-to) | 391-403 |
| Number of pages | 13 |
| Journal | Chemistry and Biology |
| Volume | 22 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 2015 Mar 19 |
Bibliographical note
Funding Information:This work was supported by grants from the National Creative Research Initiative (grant no. 2010-0018272 to I.S.) program and the National R&D program for Cancer Control (grant no. NCCR-0920300). A part of this work was carried out with support from the Korea government (MSIP) (grant no. NRF-2013R1A2A2A05005990 to Y.N.P.).
Publisher Copyright:
© 2015 Elsevier Ltd All rights reserved.
All Science Journal Classification (ASJC) codes
- Biochemistry
- Molecular Medicine
- Molecular Biology
- Pharmacology
- Drug Discovery
- Clinical Biochemistry
UN SDGs
This output contributes to the following Sustainable Development Goal(s)
